These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3567010)

  • 1. Population study of triazolam pharmacokinetics.
    Friedman H; Greenblatt DJ; Burstein ES; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Dec; 22(6):639-42. PubMed ID: 3567010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of influence of cigarette smoking on triazolam pharmacokinetics.
    Ochs HR; Greenblatt DJ; Burstein ES
    Br J Clin Pharmacol; 1987 Jun; 23(6):759-63. PubMed ID: 3606935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
    Jochemsen R; Wesselman JG; van Boxtel CJ; Hermans J; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):291S-297S. PubMed ID: 6140948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Smith RB; Shader RI
    Clin Pharmacokinet; 1984; 9(2):177-83. PubMed ID: 6143633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic noninteraction of triazolam and ethanol.
    Ochs HR; Greenblatt DJ; Arendt RM; Hübbel W; Shader RI
    J Clin Psychopharmacol; 1984 Apr; 4(2):106-7. PubMed ID: 6142906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive assay for triazolam in plasma following low oral doses.
    Edeki T; Robin DW; Prakash C; Blair IA; Wood AJ
    J Chromatogr; 1992 May; 577(1):190-4. PubMed ID: 1400742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of triazolam following sublingual versus oral administration.
    Scavone JM; Greenblatt DJ; Friedman H; Shader RI
    J Clin Pharmacol; 1986 Mar; 26(3):208-10. PubMed ID: 3958225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triazolam kinetics: interaction with cimetidine, propranolol, and the combination.
    Friedman H; Greenblatt DJ; Burstein ES; Scavone JM; Harmatz JS; Shader RI
    J Clin Pharmacol; 1988 Mar; 28(3):228-33. PubMed ID: 3360971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
    Sugimoto K; Araki N; Ohmori M; Harada K; Cui Y; Tsuruoka S; Kawaguchi A; Fujimura A
    Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Moschitto LJ; Harmatz JS; Shader RI
    Psychopharmacology (Berl); 1983; 80(3):275-8. PubMed ID: 6137021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration.
    Smith RB; Kroboth PD; Phillips JP
    J Clin Pharmacol; 1986 Feb; 26(2):120-4. PubMed ID: 3950055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
    Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam.
    Bakti G; Fisch HU; Karlaganis G; Minder C; Bircher J
    Hepatology; 1987; 7(4):629-38. PubMed ID: 3610043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.
    Otani K; Yasui N; Furukori H; Kaneko S; Tasaki H; Ohkubo T; Nagasaki T; Sugawara K; Hayashi K
    Int Clin Psychopharmacol; 1997 May; 12(3):153-7. PubMed ID: 9248872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
    Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of triazolam in geriatric patients.
    Dehlin O; Björnson G; Börjesson L; Abrahamsson L; Smith RB
    Eur J Clin Pharmacol; 1983; 25(1):91-4. PubMed ID: 6137388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazolam and ethanol interaction: kinetic and dynamic consequences.
    Dorian P; Sellers EM; Kaplan HL; Hamilton C; Greenblatt DJ; Abernethy D
    Clin Pharmacol Ther; 1985 May; 37(5):558-62. PubMed ID: 2859136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic drug interaction between erythromycin and triazolam.
    Phillips JP; Antal EJ; Smith RB
    J Clin Psychopharmacol; 1986 Oct; 6(5):297-9. PubMed ID: 3771812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazolam disposition.
    Eberts FS; Philopoulos Y; Reineke LM; Vliek RW
    Clin Pharmacol Ther; 1981 Jan; 29(1):81-93. PubMed ID: 6109586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.